Our modern world is facing extraordinary circumstances while passing through a serious pandemic caused by the novel coronavirus (COVID-19) which may lead to multi-organ system failure & death. Bcell depletion could compromise antiviral immunity, which makes the safety of rituximab use in the COVID19 era unclear.

The COVID-19 pandemic has caused delivery of orthopaedic services to require extra consideration and substantial revision. Alternative ways to manage patients with urgent injuries have been instigated to minimize patient’s exposure to the disease, spread within the hospital system and reduce the overall impact on stretched resources.

At initial (basic) training recruits from all services and most nations are subject to an intense environment where they are physically and mentally challenged throughout their waking day. Their civilian experiences and identity are systematically remodeled to fit the requirements of the nation’s services. Most recruits are able to cope with this extreme environment, albeit with some impact on their mental wellbeing, whereas those unable to cope either physically or emotionally are discharged from the Military through medical or administrative procedures.

Globally, an estimated 4.2 million people above the age of 50 now have diagnosis of HIV (Human Immunodeficiency Virus) infection. Patients with HIV can now survive well into old age. Aging with HIV has been associated with medical illness however neuropsychiatric symptoms including cognitive decline and behavioral dysregulation has been directly associated with aging and having HIV.

With artificial intelligence (AI) at the forefront of social and cultural discourse [1], it is important to recognize the scope and scale of the impact of technology use on humanbehavior